Cardiovascular Disease Prevention & Support Protocol

CardiovascularStrong Evidence

supplements

Primary

Supporting

Grade A

160

Studies

Primary Stack

Core supplements with strongest evidence

Omega-3 Fatty Acids (EPA/DHA)A

2-4g EPA/DHA daily (higher doses for elevated triglycerides)

Reduces triglycerides, decreases inflammation, improves endothelial function, and stabilizes cardiac rhythm

All-Cause Mortality↑Coronary Artery Disease Risk↓Cardiovascular Disease Mortality↑Heart Attack Risk↑Angina

50 studies150,000 participants

Supporting Studies (3)

PMID: 30415628 - REDUCE-IT trial: Icosapent ethyl cardiovascular outcomes (2019)PMID: 31567274 - Omega-3 fatty acids for cardiovascular disease: meta-analysis (2019)PMID: 27159202 - Marine omega-3 supplementation and cardiovascular outcomes (2016)

Coenzyme Q10A

100-300mg daily (ubiquinol form preferred)

Essential for mitochondrial energy production, reduces oxidative stress, and improves heart muscle function

High-density lipoprotein (HDL)↑Intercellular Adhesion Molecule 1↓Interleukin 6↓Low-density lipoprotein (LDL)↓Total cholesterol

30 studies3,000 participants

Supporting Studies (2)

PMID: 25282031 - Q-SYMBIO trial: CoQ10 in heart failure (2014)PMID: 28668236 - Coenzyme Q10 for cardiovascular disease: meta-analysis (2017)

Supporting Stack

Additional supplements for enhanced results

MagnesiumA

300-500mg daily

Regulates blood pressure, supports cardiac rhythm, and improves endothelial function

Arterial Stiffness↑Vascular Function↓Blood Pressure↓Combined Anxiety & Depression↑Serum Magnesium

25 studies2,000 participants

Supporting Studies (2)

PMID: 27402922 - Magnesium and cardiovascular health: meta-analysis (2016)PMID: 28912159 - Magnesium supplementation and blood pressure: systematic review (2017)

Vitamin K2 (MK-7)B

100-200mcg MK-7 daily

Activates matrix Gla protein to prevent arterial calcification and directs calcium to bones

CVD Events/MortalityCardiovascular Disease MortalityCVD EventsAll-Cause MortalityBlood Pressure

15 studies1,000 participants

Supporting Studies (1)

PMID: 25694037 - Vitamin K2 and vascular calcification: systematic review (2015)

CurcuminB

500-1000mg daily (enhanced bioavailability form)

Potent anti-inflammatory that improves endothelial function and reduces oxidative stress

↓Blood glucose↓Triglycerides↓Body Mass Index (BMI)↓C-Reactive Protein (CRP)↑Liver Enzymes

20 studies1,500 participants

Supporting Studies (1)

PMID: 28924596 - Curcumin and cardiovascular risk factors: meta-analysis (2017)

Aged Garlic ExtractB

600-1200mg daily

Reduces blood pressure, improves arterial stiffness, and provides antioxidant protection

↓LDL Cholesterol↓Total Cholesterol

20 studies1,200 participants

Supporting Studies (1)

PMID: 25837272 - Aged garlic extract for cardiovascular health: meta-analysis (2015)

How This Protocol Works

Simple Explanation

Cardiovascular disease (CVD) remains the leading cause of death worldwide. It develops over decades through atherosclerosis—the buildup of plaque in arteries—driven by inflammation, oxidative stress, and dyslipidemia. While medications like statins are often necessary, supplements can provide additional cardiovascular protection by targeting multiple pathways.

•Omega-3 Fatty Acids (EPA/DHA) have the strongest evidence for cardiovascular benefit. The REDUCE-IT trial showed that high-dose EPA (4g/day) reduced cardiovascular events by 25% in high-risk patients already on statins. Omega-3s lower triglycerides, reduce inflammation, improve blood vessel function, and may prevent dangerous heart rhythms. For cardiovascular protection, higher doses (2-4g) are more effective than typical 1g doses.

•Coenzyme Q10 is essential for heart muscle energy production—the heart never stops beating and has enormous energy demands. CoQ10 levels decline with age and are depleted by statin medications. The Q-SYMBIO trial showed that CoQ10 supplementation reduced major cardiovascular events by 43% in heart failure patients. It also helps lower blood pressure modestly.

•Magnesium is critical for heart health—it regulates blood pressure, maintains normal heart rhythm, and supports blood vessel function. Low magnesium increases cardiovascular risk, and deficiency is common. Supplementation can lower blood pressure by 2-5 mmHg and reduce arrhythmia risk.

•Vitamin K2 (MK-7) plays a unique role in cardiovascular health by preventing calcium from depositing in arteries. It activates proteins that keep calcium in bones and out of blood vessels. Arterial calcification is a strong predictor of heart attack risk—K2 may help prevent it.

•Curcumin is a potent anti-inflammatory that addresses the inflammatory component of atherosclerosis. It improves endothelial function (how well blood vessels dilate) and reduces oxidative stress. Use enhanced bioavailability formulations for absorption.

•Aged Garlic Extract lowers blood pressure, reduces arterial stiffness, and may slow plaque progression. Studies show significant reductions in blood pressure in people with hypertension.

Expected timeline: Blood pressure effects from magnesium and garlic within 4-8 weeks. Omega-3 effects on triglycerides within 4-6 weeks. Long-term cardiovascular protection requires sustained use over years.

Clinical Perspective

Cardiovascular disease encompasses coronary artery disease, cerebrovascular disease, and peripheral arterial disease. Pathophysiology involves endothelial dysfunction, oxidative modification of LDL, inflammatory atherosclerotic plaque formation, and thrombotic complications. Risk factors include hypertension, dyslipidemia, diabetes, smoking, and inflammation. This protocol targets multiple modifiable pathways.

•Omega-3 Fatty Acids (A-grade): EPA/DHA reduce VLDL synthesis, lower triglycerides 15-30%, and provide anti-inflammatory effects via specialized pro-resolving mediators (SPMs). REDUCE-IT trial: 4g/day icosapent ethyl (purified EPA) reduced composite CV events by 25% (HR 0.75) in high-risk patients on statins (PMID: 30415628). Also improve arterial compliance and reduce platelet aggregation. Higher doses needed for CV benefit vs general health.

•Coenzyme Q10 (A-grade): Lipid-soluble antioxidant essential for mitochondrial ATP synthesis via electron transport chain. Heart muscle highly CoQ10-dependent. Statin therapy reduces CoQ10 synthesis by 40%. Q-SYMBIO trial (n=420): 100mg 3x daily reduced composite endpoint (CV death, hospitalization, worsening HF) by 43% in chronic HF (PMID: 25282031). Also modestly reduces blood pressure. Ubiquinol form has 3-4x better absorption than ubiquinone.

•Magnesium (A-grade): Essential for >300 enzymatic reactions including Na+/K+-ATPase, cardiac ion channels, and eNOS. Hypomagnesemia associated with hypertension, arrhythmias, and increased CV mortality. Meta-analysis: supplementation reduces SBP by 2-5 mmHg (PMID: 27402922). May reduce risk of atrial fibrillation. Check RBC magnesium for accurate status.

•Vitamin K2 (MK-7) (B-grade): Activates matrix Gla protein (MGP), a potent inhibitor of vascular calcification. Coronary artery calcium (CAC) score is strong predictor of CV events. Rotterdam Study: high K2 intake associated with 50% reduced coronary heart disease mortality. MK-7 (from natto) has longer half-life than MK-4. Systematic review supports role in preventing arterial calcification (PMID: 25694037). Important for patients on vitamin D supplements.

•Curcumin (B-grade): Inhibits NF-kB, reducing inflammatory cytokines (IL-6, TNF-alpha) implicated in atherosclerosis. Improves flow-mediated dilation (endothelial function). Meta-analysis: reduces CRP, TC, LDL-C (PMID: 28924596). Use enhanced bioavailability formulations (piperine, phospholipid, nanoparticle). May interact with anticoagulants.

•Aged Garlic Extract (B-grade): S-allylcysteine and other sulfur compounds increase H2S and NO production, causing vasodilation. Meta-analysis: reduces SBP 8-10 mmHg in hypertensives (PMID: 25837272). Also reduces arterial stiffness (PWV) and may slow CAC progression. Aged form standardized and reduced odor vs raw garlic.

Biomarker targets: Blood pressure (<130/80), LDL-C (<100, or <70 for very high risk), triglycerides (<150), HDL-C (>40 M/>50 F), non-HDL-C, apoB, Lp(a), hs-CRP (<2), fasting glucose/HbA1c, coronary artery calcium score, carotid intima-media thickness.

Protocol notes: Supplements complement, not replace, guideline-directed medical therapy (statins, antihypertensives, antiplatelets as indicated). CoQ10: essential for patients on statins. Omega-3s: pharmaceutical-grade; may need prescription Vascepa for maximal benefit. K2: important if supplementing vitamin D; may affect warfarin—monitor INR. Address lifestyle: Mediterranean diet, exercise (150 min/week), smoking cessation, weight management. Secondary prevention requires more aggressive intervention. Monitor for interactions with anticoagulants/antiplatelets.

View All Protocols